Zhongtian Medical and InnoMed Enter Strategic Partnership to Advance Peripheral Vascular Innovation with Inno-Xmart Venous Stent System
Innomed
Developer and Manufacturer of Implantable Medical Devices and High-End Interventional Consumables
On December 1, 2023, Suzhou Zhongtian Medical (hereinafter referred to asZhongtian Medical) and Suzhou Innomed Medical Device Co., Ltd. (hereinafter referred to asInnomed) officially sign a strategic cooperation agreement! Both parties will fully leverage their respective advantages and resource accumulation to initiateInno-Xmart Venous Stent System(National Medical Device Registration Certificate 20233131034)The project collaboration aims to jointly address the growing demand for diagnosis and treatment of peripheral venous vascular diseases.
Strategic Cooperation Signing Ceremony
According to the content of this cooperation agreement, Suzhou Zhongtian Medical will become the venous stent system of Suzhou Innomed Medical Device Co., Ltd.Exclusive General Distributor in Mainland ChinaBoth parties will work together to advance the rapid commercialization of this product, bringing good news to a large number of patients with peripheral venous stenosis.
At the signing ceremony, Director of Suzhou Zhongtian Medical and Sales & MarketingMr. Chen ChongWith Suzhou Innomed Medical Device Co., Ltd. Marketing Director and Overseas Sales DirectorMr. Chen HuaRepresenting their respective companies, they attended and signed the strategic cooperation agreement.
China's first approved braided venous stent,Can Benefit Millions of Venous Stenosis Patients
According to experts at home and abroad, about 25% of people globally are at risk of iliac vein stenosis. Severe iliac vein stenosis or occlusion can lead to obstruction of venous reflux in the lower limbs, which, if not treated effectively, will seriously affect the patient's quality of life. However, there are very few stents available on the market for treating venous stenosis. Arterial stents are often used as substitutes during interventional surgeries, but their off-label use carries a risk of postoperative complications.
As a new partner of Zhongtian Medical, Suzhou Innomed Medical Device Co., Ltd.'s venous stent system boasts excellent quality and technical advantages. Its developmentInno-Xmart Venous Stent SystemMainly used in the iliac and femoral veins to treat symptomatic venous obstruction.
Inno-Xmart Venous Stent System
Inno-Xmart Venous Stent System is the first domestically produced seamless braided stent made of nickel-titanium alloy in China. Due to its use of seamless braiding with nickel-titanium alloy wires, it can self-expand after deployment and provides sufficient radial support to prevent migration. The unique bionic structure of the stent ensures that it has adequate radial support while offering excellent fatigue resistance, effectively preventing stent fractures in vivo. Additionally, the system features three stent designs to accommodate the anatomical structure of the human iliac veins.
Three Types of Stent Designs
At the same time, the Inno-Xmart venous stent delivery system has a self-compensation mechanism that can solve the problem of braided stent shortening, ensuring accurate positioning. Additionally, the venous stent system adopts a retrievable design, allowing for stent retrieval and re-deployment before it is completely released from the delivery system. This facilitates physicians' secondary positioning to handle emergencies during the delivery process and enhances the safety of device operation.
Based on its unique and innovative design, the product has successfully passed through the National Medical Products Administration (NMPA) expedited review channel for innovative products in 2019.
Inno-Xmart Venous Stent Delivery System
Excellent anti-fatigue performance, with a patency rate exceeding 96% one year after implantation.
Generally speaking, peripheral laser-cut stents tend to have the risk of fracture in vivo. However, the Inno-Xmart stent exhibits excellent flexibility, resistance to flat plate compression, and fatigue resistance. It has undergone accelerated fatigue testing with 10 million cycles of bending, flat plate compression, and torsion without any fractures, as well as radial fatigue testing with 380 million cycles without any fractures.
Data from overseas published venous stent product registration clinical trials (data source: FDA official website PMA database) and completed two-year follow-up iliac-femoral venous stent clinical studies show that the long-term patency rate of anti-fatigue stents is superior to that of laser-cut stents (see Figure 1).
Figure 1: 12-Month Patency Rate of PMA-Approved Venous Stents and Inno-Xmart Post-Surgery
At this signing ceremony,Mr. Chen Chong, Director and Sales & Marketing Director of Zhongtian MedicalDelivered an important speech, pointing out that the current scale of patients with peripheral vascular diseases is enormous. In recent years, there has been significant progress in the treatment concepts for peripheral vascular diseases among doctors and patients. The medical devices required for peripheral diseases need to keep up with the demands of clinical and market development. Over the past five years, Zhongtian Medical has achieved a leading position in China for multiple products, thanks to its internationally advanced technology platform and a mature, professional commercialization team. In the future, Zhongtian Medical will continue to leverage its accumulated technical R&D advantages and commercialization experience in the field of neurointervention to rapidly expand its product range for treating peripheral vascular diseases and accelerate its layout in this field.
This strategic cooperation with Innomed will further improve China Tian Medical's layout in the peripheral product line, providing more treatment options for a wide range of patients. At the same time, China Tian Medical will continue to uphold its corporate mission of "Innovative technology makes vascular treatment simpler," and strive to advance a new chapter of Healthy China by absorbing diverse strengths through independent innovation and industry collaboration.
Innomed Marketing Director and Overseas Sales DirectorIn his speech at the ceremony, he noted that Innomed, as a national high-tech enterprise specializing in the development and manufacturing of endovascular implant and interventional medical devices, has gained significant recognition in the industry over the years for its high-quality innovative products. This cooperation with Zhongtian Medical represents a major strategic move for Innomed's future development. Based on a shared vision, both parties will focus on addressing the diagnostic and treatment needs of peripheral venous vascular diseases, benefiting more families in China.
This strategic cooperation is the continuation of Zhongtian Medical's...China TianhangTMPro Peripheral Thrombus Aspiration Catheter, Zhongtian TianjiTMPeripheral Thrombus SeparatorAndNegative Pressure Suction Device SystemAnother milestone after obtaining certification, marking that Zhongtian Medical has opened a new commercial cooperation model. Through continuous independent innovation and the absorption of industry innovation forces, it further accelerates its expansion speed as an "emerging force in peripheral treatments," providing better treatment options and health benefits for a wide range of patients.
New Force in Peripheral Aspiration | Innomed's Peripheral Thrombus Aspiration Certification and Products
Explanation Tweet Link
About Zhongtian
Learn More
Copyright Statement: This platform aims to help healthcare professionals better understand the latest developments in relevant disease areas. The information content published on this platform does not imply agreement with its descriptions and viewpoints, but is only for providing more information. If there are any copyright issues, we kindly request the rights holders to contact us, and we will handle them as soon as possible. The information is solely for healthcare professionals to stay informed, and such information cannot replace professional medical guidance in any way, nor should it be regarded as medical advice. If such information is used for purposes other than staying informed, this platform and the author shall not bear any related responsibilities.Contact Email for Cooperation:vascular@edoctor.cn。
